Literature DB >> 21664377

Timbre discrimination in cochlear implant users and normal hearing subjects using cross-faded synthetic tones.

Torsten Rahne1, Lars Böhme, Gerrit Götze.   

Abstract

The identification and discrimination of timbre are essential features of music perception in cochlear implant users. As timbre differences appear as multidimensional cues, the spectral shape, the spectral fluctuation, and the rise time are the most dominating parameters of timbre in normal hearing listeners. Recently, a psychoacoustical test was developed to determine the timbre discrimination abilities using only the spectral shape difference as a cue. Therefore, a synthetically generated tone continuum was used in an adaptive alternative forced choice paradigm. The spectral shape was modified by cross-fading the tones adaptively, depending on the listeners' response which allows very precise determinations of the just noticeable difference (JND). With this behavioral test, the spectral shape JND for complex tones with different fundamental frequencies was measured in cochlear implant users and compared to normal hearing listeners. The results confirm the applicability of the test to measure timbre discrimination in cochlear implant users. The resulting individual spectral shape JND profiles reveal a maximum with a fundamental frequency of 525 Hz, whereas the JND profiles were rather flat in the normal hearing individuals.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Year:  2011        PMID: 21664377     DOI: 10.1016/j.jneumeth.2011.05.022

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  2 in total

1.  Influence of implantable hearing aids and neuroprosthesison music perception.

Authors:  Torsten Rahne; Lars Böhme; Gerrit Götze
Journal:  ScientificWorldJournal       Date:  2012-05-03

2.  The Perception of Stress Pattern in Young Cochlear Implanted Children: An EEG Study.

Authors:  Niki K Vavatzanidis; Dirk Mürbe; Angela D Friederici; Anja Hahne
Journal:  Front Neurosci       Date:  2016-03-08       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.